Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

States sue over Trump cutting off ACA insurer subsidies

Eighteen states and the District of Columbia have announced a lawsuit against the administration of President Donald Trump over his move to halt payment of cost-sharing reduction subsidies, or CSRs, to insurers on the Affordable Care Act (ACA) exchanges.

Thumbnail

Industry groups blast Trump’s executive order on insurance regulations

Groups representing physicians, hospitals and patients came out largely in opposition to President Donald Trump’s executive order to encourage the use of insurance plans which don’t comply with Affordable Care Act (ACA) regulations on benefits and covering people with pre-existing conditions.

Thumbnail

Trump to cut off ACA insurer subsidies ‘immediately’

Cost-sharing reduction subsidies, or CSRs, paid to insurers in exchange for keeping out-of-pocket costs low for lower-income Affordable Care Act (ACA) exchange enrollees will end, HHS announced Thursday night, with the agency saying it couldn’t legally continue making the payments.

Thumbnail

Trump signs executive order removing ACA regulations on small businesses

President Donald Trump signed an executive order on the morning of Oct. 12 to ease rules on small businesses buying health insurance. With Congress failing to act on Republican promises to repeal and replace the Affordable Care Act (ACA), Trump will make the unilateral move to reconfigure federal regulations.

Thumbnail

AHIMA17: Former congressional leaders think ACA fixes, not repeal, now more likely

Former House Speaker Newt Gingrich and former U.S. Sen. Barbara Boxer, D-California, were brought to the American Health Information Management Association (AHIMA) conference in Los Angeles to have a political-style debate on healthcare policy, but ended up agreeing on where short-term efforts may go now that repeal of the Affordable Care Act (ACA) failed to pass.

Thumbnail

ONC’s Don Rucker at AHIMA17: Blockchain ‘not there yet’ for regulation

Don Rucker, MD, head of the Office of the National Coordinator for Health IT (ONC) said his agency has been focused on improving usability and interoperability of electronic health records, adding that while blockchain technology may provide some interesting capabilities but it’s too soon to issue regulations on it.

Thumbnail

5 recommendations improving mHealth for adolescent use

A study published in JMIR mHealth and uHealth includes a list of five recommendations for improving mHealth utilization for adolescents with chronic conditions. The researched aimed at improving disease self-management in adolescents by utilizing mHealth technology for real-time care.

Thumbnail

Q&A with MGMA’s Anders Gilberg: Lasting healthcare reform ‘needs to start in the middle’

To call the last few months a busy time for healthcare lobbyists in Washington, D.C. would be quite an understatement. Rather than dwell on the failed attempts at repealing the Affordable Care Act, the Medical Group Management Association’s (MGMA) senior vice president of government affairs, Anders Gilberg, will look ahead to more immediate regulatory concerns and longer-term hopes for “lasting reform.”

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup